Heroin metabolism in human blood and its impact for the design of an immunotherapeutic approach against heroin effects
Basic & Clinical Pharmacology & Toxicology · 2023
DOI: 10.1111/bcpt.13926 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2023. Verfasst von Inger Lise Bogen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section for Drug Abuse Research, Department of Forensic Sciences, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Heroin, Immunotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Research Council of Norway, Norges Forskningsråd.
Abstract (Originalsprache)
Immunotherapeutic interventions that block drug effects by binding drug molecules to specific antibodies in the bloodstream have shown promising effects in animal studies. For heroin, which effects are mainly mediated by the metabolites 6‐acetylmorphine (6‐AM; also known as 6‐monoacetylmorphine or 6‐MAM) and morphine, the optimal antibody specificity has been discussed. In rodents, 6‐AM specific antibodies have been recommended based on the rapid metabolism of heroin to 6‐AM in the bloodstream. Since the metabolic rate of heroin in blood is unsettled in humans, we examined heroin metabolism with state‐of–the‐art analytical methodology (UHPLC–MS/MS) in freshly drawn human whole blood incubated with a wide range of heroin concentrations (1–500 μM). The half‐life of heroin was highly concentration dependent, ranging from 1.2–1.7 min for concentrations at or above 25 μM, and gradually increasing to approximately 20 min for 1 μM heroin. At concentrations that can be attained in the bloodstream shortly after an i.v. injection, approximately 70% was transformed into 6‐AM within 3 min, similar to previous observations in vivo. Our results indicate that blood enzymes play a more important role for the rapid metabolism of heroin in humans than previously assumed. This points to 6‐AM as an important target for an efficient immunotherapeutic approach to block heroin effects in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section for Drug Abuse Research, Department of Forensic Sciences, Oslo University Hospital, Oslo, Norway.
- Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.
- Division of Health Data and Digitalisation, Norwegian Institute of Public Health, Oslo, Norway.
- Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
ORCID-Profile: Inger Lise Bogen, Fernando Boix, Jannike Mørch Andersen, Jørg Mørland
Förderung
- Research Council of Norway
- Norges Forskningsråd
Zitieren
APA
Bogen, I. L., Boix, F., Andersen, J. M., Steinsland, S., Nerem, E., & Mørland, J. (2023). Heroin metabolism in human blood and its impact for the design of an immunotherapeutic approach against heroin effects. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.13926
Vancouver
Bogen IL, Boix F, Andersen JM, Steinsland S, Nerem E, Mørland J. Heroin metabolism in human blood and its impact for the design of an immunotherapeutic approach against heroin effects. Basic & Clinical Pharmacology & Toxicology. 2023. doi:10.1111/bcpt.13926
BibTeX
@article{Bogen2023,
author = {Bogen, Inger Lise and Boix, Fernando and Andersen, Jannike Mørch and Steinsland, Synne and Nerem, Elisabeth and Mørland, Jørg},
title = {Heroin metabolism in human blood and its impact for the design of an immunotherapeutic approach against heroin effects},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2023},
doi = {10.1111/bcpt.13926}
}
EUVIMED